Summary
Atopic dermatitis (AD) or atopic eczema is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Although the condition affects people of all ages, it is primarily common among infants and children. Modifiable risk factors include inhalant allergens, food allergens, and newborns not being exclusively breastfed, while non-modifiable risk factors include young age and genetics or heritability.
This epidemiology forecast for AD is supported by historical data obtained from peer-reviewed articles and population-based studies. These sources used questionnaires and various diagnostic measures to assess AD symptoms across the 7MM. The forecast methodology was kept consistent across the 7MM to allow for a meaningful comparison of AD across these markets.
In the 7MM, the one-year total prevalent cases of AD are expected to increase from 81,608,107 cases in 2017 to 83,639,767 cases in 2027, at an Annual Growth Rate (AGR) of 0.25%. In the 7MM, the one-year diagnosed prevalent cases of AD are expected to increase from 36,109,879 cases in 2017 to 36,873,084 cases in 2027, at an AGR of 0.21%. In 2027, the US will have the highest number of one-year diagnosed prevalent cases of AD in the 7MM with 18,236,642 diagnosed prevalent cases, whereas Germany will have the fewest number of one-year diagnosed prevalent cases with 1,797,130 cases.
Scope
- The Atopic Dermatitis (AD) Epidemiology Forecast Report provides an overview of the risk factors and global trends of AD in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
- This report also includes a 10-year epidemiological forecast for the one-year total prevalent cases (both diagnosed and undiagnosed) and one-year diagnosed prevalent cases of AD segmented by sex, age, and severity (mild, moderate, and severe) in the 7MM.
- The Atopic Dermatitis epidemiology forecast report is written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Forecast Report is in-depth, high quality, transparent, and market-driven, providing expert analysis of disease trends in the 7MM.
Reasons to buy
The Atopic Dermatitis (AD) Epidemiology Forecast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global AD market.
- Quantify patient populations in the global AD market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for AD therapeutics in each of the markets covered.
- Understand magnitude of AD population by severity and other clinically relevant segmentations.
'
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Atopic Dermatitis: Executive Summary 4
2.1 Related Reports 6
2.2 Upcoming Reports 6
3 Epidemiology 7
3.1 Disease Background 7
3.2 Risk Factors and Comorbidities 7
3.3 Global and Historical Trends 8
3.4 Forecast Methodology 9
3.4.1 Sources 10
3.4.2 Forecast Assumptions and Methods - Population 12
3.4.3 Forecast Assumptions and Methods - One-Year Total and Diagnosed Prevalent Cases of Atopic Dermatitis 13
3.4.4 Forecast Assumptions and Methods - One-Year Total Prevalent Cases of Atopic Dermatitis by Severity 14
3.4.5 Forecast Assumptions and Methods - One-Year Diagnosed Prevalent Cases of Atopic Dermatitis by Severity 15
3.5 Epidemiological Forecast for Atopic Dermatitis (20172027) 15
3.5.1 One-Year Total Prevalent Cases of Atopic Dermatitis 15
3.5.2 Age-Specific One-Year Total Prevalent Cases of Atopic Dermatitis 17
3.5.3 Sex-Specific One-Year Total Prevalent Cases of Atopic Dermatitis 18
3.5.4 One-Year Total Prevalent Cases of Atopic Dermatitis by Severity 19
3.5.5 One-Year Diagnosed Prevalent Cases of Atopic Dermatitis 20
3.5.6 Age-Specific One-Year Diagnosed Prevalent Cases of Atopic Dermatitis 21
3.5.7 Sex-Specific One-Year Diagnosed Prevalent Cases of Atopic Dermatitis 22
3.5.8 One-Year Diagnosed Prevalent Cases of Atopic Dermatitis by Severity 23
3.6 Discussion 24
3.6.1 Epidemiological Forecast Insight 24
3.6.2 Limitations of the Analysis 24
3.6.3 Strengths of the Analysis 25
4 Appendix 26
4.1 Bibliography 26
4.2 About the Authors 28
4.2.1 Epidemiologist 28
4.2.2 Reviewers 28
4.2.3 Global Director of Therapy Analysis and Epidemiology 29
4.2.4 Global Head and EVP of Healthcare Operations and Strategy 29
4.3 About GlobalData 30
4.4 Contact Us 30
4.5 Disclaimer 30
1.1 List of Tables
Table 1: Risk Factors and Comorbid Conditions Associated with Atopic Dermatitis 8
1.2 List of Figures
Figure 1: One-Year Total Prevalent Cases of AD, Both Sexes, All Ages, N, 2017 and 2027 5
Figure 2: One-Year Diagnosed Prevalent Cases of AD, Both Sexes, All Ages, N, 2017 and 2027 5
Figure 3: 7MM, Age-Standardized One-Year Total Prevalence of Atopic Dermatitis (%), Both Sexes, All Ages, 2017 9
Figure 4: 7MM, Sources Used and Not Used to Forecast the One-Year Total and Diagnosed Prevalent Cases of Atopic Dermatitis 10
Figure 5: 7MM, Sources Used to Forecast the One-Year Total Prevalence by Severity of Atopic Dermatitis 11
Figure 6: 7MM, Sources Used to Forecast the One-Year Diagnosed Prevalent Cases by Severity of Atopic Dermatitis 12
Figure 7: 7MM, One-Year Total Prevalent Cases of Atopic Dermatitis, Both Sexes, All Ages, N, 2017 16
Figure 8: 7MM, Age-Specific One-Year Total Prevalent Cases of Atopic Dermatitis, Both Sexes, All Ages, N, 2017 17
Figure 9: 7MM, Sex-Specific One-Year Total Prevalent Cases of Atopic Dermatitis, All Ages, N, 2017 18
Figure 10: 7MM, One-Year Total Prevalent Cases of Atopic Dermatitis by Severity, Both Sexes, All Ages, N, 2017 19
Figure 11: 7MM, One-Year Diagnosed Prevalent Cases of Atopic Dermatitis, Both Sexes, All Ages, N, 2017 20
Figure 12: 7MM, Age-Specific One-Year Diagnosed Prevalent Cases of Atopic Dermatitis, Both Sexes, All Ages, N, 2017 21
Figure 13: 7MM, Sex-Specific One-Year Diagnosed Prevalent Cases of Atopic Dermatitis, All Ages, N, 2017 22
Figure 14: 7MM, One-Year Diagnosed Prevalent Cases by Severity of Atopic Dermatitis, Both Sexes, All Ages, N, 2017 23
